| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000026801 |
| Receipt No. | R000030752 |
| Official scientific title of the study | A study about pathogenic diagnosis of Mycoplasma pneumoniae pneumonia |
| Date of disclosure of the study information | 2017/03/31 |
| Last modified on | 2017/03/31 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | A study about pathogenic diagnosis of Mycoplasma pneumoniae pneumonia | |
| Title of the study (Brief title) | A study about pathogenic diagnosis of Mycoplasma pneumoniae pneumonia | |
| Region |
|
|
| Condition | |||
| Condition | Mycoplasma pneumoniae pneumonia | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Recently, a rapid antigen detection assay for L7/L12 ribosomal protein (Ribotest Mycoplasma; Asahi Kasei) for diagnosis of Mycoplasma pneumoniae infection became available in Japan. However, the clinical usefulness of Ribotest is not established. To clarify the usefulness of Ribotest, we diagnosed with Mycoplasma pneumoniae pneumonia using Ribotest, both in non-epidemic period and in epidemic period. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Sensitivities, specificities and positive predictive values of Ribotest for M. pneumoniae pneumonia |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Eligible patients were otherwise healthy children 0 - 18 years of age who were admitted with community-acquired pneumonia | |||
| Key exclusion criteria | We excluded the subjects from whom throat swabs or paired serum samples were not obtained. | |||
| Target sample size | 1000 | |||
| Research contact person | |
| Name of lead principal investigator | Naoko Nishimura |
| Organization | Konan Kosei Hospital |
| Division name | Departments of Pediatrics |
| Address | 137 Ohmatsubara, Takaya-cho, Konan-shi, Aichi 483-8704, Japan |
| TEL | 0587-51-3333 |
| naon@konan.jaaikosei.or.jp | |
| Public contact | |
| Name of contact person | Kensei Gotoh |
| Organization | Konan Kosei Hospital |
| Division name | Departments of Pediatrics |
| Address | 137 Ohmatsubara, Takaya-cho, Konan-shi, Aichi 483-8704, Japan |
| TEL | 0587-51-3333 |
| Homepage URL | |
| idecc2b7@gmail.com | |
| Sponsor | |
| Institute | Konan Kosei Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Konan Kosei Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| URL releasing results | |
| Results | We presented the results at the 47th annual meeting of the Japanese Society for Pediatric Infectious Diseases on November 1, 2015. |
| Other related information | Prospective study |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030752 |